Ji Li, PhD, assistant professor of pharmacology and toxicology,
received a $198,000 grant to study a novel signaling pathway that,
when activated, helps protects the heart from damage caused by
ischemia.
Innovations developed at least in part by faculty at UB’s
School of Medicine and Biomedical Sciences accounted for nearly 40
percent of the provisional patent applications filed by the
university in 2012.
Jun-Xu Li, MD, PhD, has been named councilor of the Behavioral
Pharmacology Division of the American Society of Pharmacology
and Experimental Therapeutics.